Meet us at the Anglonordic Life Science Conference in London. http://anglonordic.biopartnering.co.uk/
Sartar will pitch at the Life Sciences Venture Market 2018! http://www.stiftung-charite.de/en/events/charite-entrepreneurship-summit.html
Sartar will give a presentation at the 2nd KYOTO−SPARK Symposium.
The Vice-Chairman of the Board and a co-founder the Sartar Therapeutics Professor Heikki Joensuu has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation. Congratulations Heikki on your new appointment!
Sartar was awarded a USA patent for use of anagrelide in cancer therapy.